Showing results (51-60 of 129) with videos related to

Sort By:
Pageof 13
Antimicrobial Agents and Chemotherapy|August 8, 2012
Characterization of resistance to the protease inhibitor GS-9451 in hepatitis C virus-infected patientsHadas Dvory-Sobol, Kelly A Wong, Karin S Ku, et al.
Antiviral Therapy|October 25, 2017
Characterization of HCV resistance from a 3-day monotherapy study of voxilaprevir, a novel pangenotypic NS3/4A protease inhibitorEric Lawitz, Jenny C Yang, Luisa M Stamm, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2011
Contribution of a mutational bias in hepatitis C virus replication to the genetic barrier in the development of drug resistanceMegan H Powdrill, Egor P Tchesnokov, Robert A Kozak, et al.
Journal of Medical Virology|March 13, 2019
Comparison of the efficacy of sofosbuvir plus ribavirin in Chinese patients with genotype 3a or 3b HCV infectionRui Huang, Huiying Rao, Qing Xie, et al.
Antimicrobial Agents and Chemotherapy|August 27, 2014
Clinical and in vitro resistance to GS-9669, a thumb site II nonnucleoside inhibitor of the hepatitis C virus NS5B polymeraseHadas Dvory-Sobol, Christian Voitenleitner, Eric Mabery, et al.
Antiviral Therapy|March 2, 2017
In vitro selection of resistance to sofosbuvir in HCV replicons of genotype-1 to -6Simin Xu, Brian Doehle, Sonal Rajyaguru, et al.
Antimicrobial Agents and Chemotherapy|June 30, 2016
Clinical Resistance to Velpatasvir (GS-5816), a Novel Pan-Genotypic Inhibitor of the Hepatitis C Virus NS5A ProteinEric J Lawitz, Hadas Dvory-Sobol, Brian P Doehle, et al.
Antiviral Research|September 29, 2004
Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazolesTim Middleton, Hock B Lim, Debra Montgomery, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2004
Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitroLiangjun Lu, Tami J Pilot-Matias, Kent D Stewart, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2016
Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based TherapiesChristoph Sarrazin, Vasily Isakov, Evguenia S Svarovskaia, et al.
Pageof 13